Therapeutic Plateletpheresis in a Case of Symptomatic Thrombocytosis in Chronic Myeloid Leukemia

Abstract:  Extreme thrombocytosis is a frequent feature in myeloproliferative disorders which can predispose a person to thrombotic complications. As opposed to other myeloproliferative disorders, symptomatic thrombocytosis is rare in chronic myeloid leukemia. We describe a second case report of chronic myeloid leukemia (Ph chromosome positive) in a patient in chronic phase on hydroxyurea who presented with sudden onset digital cyanosis of the left hand, giddiness, headache and malaise due to extreme thrombocytosis. A 67% global reduction in the platelet count from 1553 × 109/L to 513 × 109/L after two therapeutic plateletpheresis procedures was seen. There was simultaneous improvement in all symptoms except cyanosis on the tip of the middle finger that progressed to dry gangrene. Dramatic reduction in the platelet count and ablation of symptoms by therapeutic plateletpheresis is an effective therapy and should begin as soon as possible.

[1]  L. Simon,et al.  Rossi's Principles of Transfusion Medicine , 2002 .

[2]  D. Ertuğrul,et al.  Circulating Thrombopoietin in Clonal Versus Reactive Thrombocytosis , 2002, Hematology.

[3]  D. Mitchell,et al.  Platelet apheresis for digital gangrene due to thrombocytosis in chronic myeloid leukaemia. , 2001, Clinical and Laboratory Haematology.

[4]  H. Kantarjian,et al.  Expression of thrombopoietin and its receptor (c‐mpl) in chronic myelogenous leukemia , 2000, Cancer.

[5]  R. Zimmermann,et al.  The influence of automated plateletpheresis on systemic levels of hematopoietic growth factors , 1999, Transfusion.

[6]  P. Petrides,et al.  Anagrelide for treatment of patients with chronic myelogenous leukemia and a high platelet count. , 1998, Blood cells, molecules & diseases.

[7]  L. Case,et al.  Occurrence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases. , 1994, The American journal of medicine.

[8]  A. Schafer.  Bleeding and thrombosis in the myeloproliferative disorders. , 1984, Blood.

[9]  T. J. Myers,et al.  Hyperviscosity in chronic granulocytic leukemia , 1980, Cancer.

[10]  R. Schilling.  PLATELET MILLIONAIRES , 1980, The Lancet.

[11]  A. Singh,et al.  Microvascular Occlusive Lesions in Primary Thrombocythaemia , 1977, British journal of haematology.

[12]  V. Devita,et al.  Thrombocytosis in chronic granulocytic leukemia: incidence and clinical significance. , 1974, Blood.

[13]  D. Winfield,et al.  Essential Thrombocythaemia and Peripheral Gangrene , 1974, British medical journal.

[14]  J. Mateo,et al.  Patients with thrombocytosis have normal or slightly elevated thrombopoietin levels. , 1999, Haematologica.

[15]  H. Kohler.  Letter: Feto-fetal transfusion and fetal vascular anomaly. , 1975, Lancet.